Skip to content

Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Exercise Performance in Humans.

Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Cardiorrespiratory, Neuromuscular and Hormonal Responses in Healthy Males.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02117193
Enrollment
10
Registered
2014-04-17
Start date
2013-10-31
Completion date
2015-05-31
Last updated
2016-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Intake, Sleep Deprivation

Brief summary

Although the effects of acute alcohol intake and sleep deprivation on exercise performance lacks evidence in the literature, in many situations, they occur simultaneously. Once the alcohol affects physiological processes, the processes that occur during sleep can be impaired, such as: suppression of GH release, action of neurotransmitters and neuromodulators in the CNS, changes in the proportion of sleep stages and may lead to suppression of REM sleep. These changes promote a significant functional impairment such as a reduction in alertness and modification in reaction time, which affects the performance of any activity of daily and professional life. However, the combined effects on the physical performance variables, such as aerobic and neuromuscular performance lack of evidence in the literature.

Detailed description

Ten subjects were randomized in four situations after familiarization and control situation: (1) alcohol intake combined with sleep normal; (2) alcohol intake combined with sleep deprivation; (3) placebo intake combined with sleep normal and (4) placebo intake combined with sleep deprivation.

Interventions

The subjects will be drink beer (with or without alcohol) before sleep intervention (normal sleep and sleep deprivation).

OTHERSleep deprivation

One night of sleep deprivation or one night of normal sleep.

Sponsors

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
CollaboratorOTHER
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Federal University of Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

\- Physical active men

Exclusion criteria

* AUDIT questionnaire above 15 points * Nocturnal Chronotype * Skeletal muscle injuries in upper and lower limb * Metabolic and cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Aerobic PerformanceAfter each sequence, up to 8 hoursAerobic performance will be determined through the subject's heart rate
Neuromuscular PerformanceAfter each sequence, up to 8 hoursknee extensor isometric torque
Biochemical ResponsesAfter each sequence, up to 8 hoursGlucose after each situation in the morning

Secondary

MeasureTime frameDescription
Hydration StatusAfter each sequence, up to 8 hoursUrine Specific Gravity
Profile of Mood States6 months
Breath Alcohol6 months

Countries

Brazil

Participant flow

Participants by arm

ArmCount
All Study Participants
Received Alcohol intake + Normal Sleep Received Alcohol intake + Sleep Deprivation Received Placebo intake + Normal Sleep Received Placebo intake + Sleep Deprivation
10
Total10

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous23.5 years
STANDARD_DEVIATION 3.3
Gender
Female
0 Participants
Gender
Male
10 Participants
maximal oxygen uptake44.8 ml.kg-1.min-1
STANDARD_DEVIATION 2.4
Region of Enrollment
Brazil
10 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
5 / 108 / 100 / 103 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 100 / 10

Outcome results

Primary

Aerobic Performance

Aerobic performance will be determined through the subject's heart rate

Time frame: After each sequence, up to 8 hours

ArmMeasureValue (MEAN)Dispersion
Sequence 1Aerobic Performance172 bpmStandard Deviation 12.19
Sequence 2Aerobic Performance173 bpmStandard Deviation 9.2
Sequence 3Aerobic Performance175 bpmStandard Deviation 6.5
Sequence 4Aerobic Performance176 bpmStandard Deviation 11.4
Primary

Biochemical Responses

Glucose after each situation in the morning

Time frame: After each sequence, up to 8 hours

ArmMeasureValue (MEAN)Dispersion
Sequence 1Biochemical Responses89.82 mg/dlStandard Deviation 6.6
Sequence 2Biochemical Responses84.76 mg/dlStandard Deviation 4.03
Sequence 3Biochemical Responses92.77 mg/dlStandard Deviation 5.13
Sequence 4Biochemical Responses92.85 mg/dlStandard Deviation 8.26
Primary

Neuromuscular Performance

knee extensor isometric torque

Time frame: After each sequence, up to 8 hours

ArmMeasureValue (MEAN)Dispersion
Sequence 1Neuromuscular Performance260.8 NmStandard Deviation 27.9
Sequence 2Neuromuscular Performance242.3 NmStandard Deviation 34.3
Sequence 3Neuromuscular Performance258.9 NmStandard Deviation 31.3
Sequence 4Neuromuscular Performance249.5 NmStandard Deviation 33.9
Secondary

Breath Alcohol

Time frame: 6 months

Secondary

Hydration Status

Urine Specific Gravity

Time frame: After each sequence, up to 8 hours

ArmMeasureValue (MEAN)Dispersion
Sequence 1Hydration Status1.017 g/mlStandard Deviation 0.006
Sequence 2Hydration Status1.017 g/mlStandard Deviation 0.005
Sequence 3Hydration Status1.015 g/mlStandard Deviation 0.003
Sequence 4Hydration Status1.011 g/mlStandard Deviation 0.006
Secondary

Profile of Mood States

Time frame: 6 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026